Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries

BACKGROUND: Less than one-third of patients who are estimated to be infected with multidrug-resistant tuberculosis (MDR-TB) receive MDR-TB treatment regimens, and only 48% of those who received treatment have successful outcomes. Despite current regimens, newer, more effective and cost-effective app...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xiaoyan, Smare, Caitlin, Kambili, Chrispin, El Khoury, Antoine C., Wolfson, Lara J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267460/
https://www.ncbi.nlm.nih.gov/pubmed/28122562
http://dx.doi.org/10.1186/s12913-016-1931-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267460/
https://www.ncbi.nlm.nih.gov/pubmed/28122562
http://dx.doi.org/10.1186/s12913-016-1931-3

Ejemplares similares